Advancing Cancer Treatment with Therapeutic Vaccines – MSKCC
Memorial Sloan Kettering Cancer Center (MSKCC) shared a post on X:
“Researchers at MSK continue to build upon early ideas in cancer research, breaking new ground and driving the field now known as ‘immunotherapy’ forward.
Today, one specific type of immunotherapy —therapeutic cancer vaccines — has taken center stage. Unlike traditional vaccines, which prevent disease, a cancer vaccine would actually treat the disease.
The concept is audacious. It is challenging. And it is also achievable, thanks to new technology and more support for researchers in the lab and the clinic.
Learn more from some of the MSK experts in this field, including Dr. David Scheinberg, Vinod Balachandran, Benjamin D. Greenbaum, and Eileen M O’Reilly.”
More posts featuring Memorial Sloan Kettering Cancer Center on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023